abdominal elective laparoscopic.
Conditions
Interventions
Intervention 1: Control group: 2 milligram per kilogram Ropivacaine 0.5 % (Molteni Co.Italia) use that total volume of it is adjusted to 50 milliliter with normal saline (Daropakhsh.Co). Intervention
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients candidate laparoscopic abdominal surgery 18 to 65 years old No susceptibility to used drugs Absence of cardiovascular disease and endocrine and renal disease No smoking and no addiction No pregnancy Body mass index more than 35
Exclusion criteria
Exclusion criteria: No willingness to continue the study Refusal of the patient to inject intraperitoneally Patient that requires the insertion of a drain inside the abdomen for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial blood pressure. Timepoint: Every 30 minutes during surgery and recovery and 2 hours after surgery. Method of measurement: Barometer.;Heart rate. Timepoint: Every 30 minutes during surgery and recovery and 2 hours after surgery. Method of measurement: Count.;Percent of oxygen saturation. Timepoint: Every 30 minutes during surgery and recovery and 2 hours after surgery. Method of measurement: Pulse oximetry.;Pain. Timepoint: At recovery and 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Visual Analogue Scale Questionnaire.;Amount of opioids consumed during surgery. Timepoint: End of surgery. Method of measurement: Milligram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Bijan Yazdi
Arak University of Medical Sciences
Outcome results
None listed